Volpara Health Technologies Ltd traded at 1.15 this Friday May 3rd, increasing 0.01 or 0.44 percent since the previous trading session. Looking back, over the last four weeks, Volpara Health Technologies gained 1.33 percent. Over the last 12 months, its price rose by 53.69 percent. Looking ahead, we forecast Volpara Health Technologies Ltd to be priced at 1.12 by the end of this quarter and at 1.06 in one year, according to Trading Economics global macro models projections and analysts expectations.
Volpara Health Technologies Limited is a New Zealand-based company, which is engaged in selling and providing services in the medical device and practice management software industry. The Company provides its goods and services under three product categories: software as a service (SaaS) contract, software maintenance agreements (SMAs) and capital sales contracts. Software as a service (SaaS) contract involves the sale of software on a subscription basis and, where applicable, cloud-based support. SaaS contracts comprise a range of goods and services, including the base software, software updates and upgrades, installation, integrations, and other. Software maintenance agreements (SMAs) support previous capital sales. SMA contracts comprise a number of distinct performance obligations, including the provision of software updates, upgrades, provision of ongoing technical support, and other. Capital sales contracts involve the outright sale of software and associated items.